OTC Pharmaceuticals - Qatar

  • Qatar
  • The OTC Pharmaceuticals market in Qatar is projected to generate a revenue of US$326.70m in 2024.
  • It is expected to witness an annual growth rate of 5.62% (CAGR 2024-2029).
  • Among the various markets, Analgesics holds the largest market share with a volume of US$88.29m in 2024.
  • On a global scale, the in the United States leads in terms of revenue generation, reaching US$41,240.00m in 2024.
  • When considering the population size, the per person revenue stands at US$119.30 in 2024.
  • In the OTC Pharmaceuticals market of Qatar, online sales are expected to contribute 0.45% of the total revenue by 2024.
  • Qatar's OTC Pharmaceuticals market is witnessing a surge in demand for natural and herbal remedies due to the growing preference for alternative medicine in the country.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Qatar has been experiencing significant growth in recent years.

Customer preferences:
Customers in Qatar are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This is due to several factors, including convenience, accessibility, and the ability to self-diagnose and self-treat minor ailments. Additionally, the rising cost of prescription medications has led many consumers to seek more affordable alternatives, further driving the demand for OTC pharmaceuticals.

Trends in the market:
One of the major trends in the OTC Pharmaceuticals market in Qatar is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking products that are perceived to be more natural and less chemically-based. This trend is in line with the global shift towards holistic and alternative medicine.Another trend in the market is the growing demand for OTC pharmaceuticals targeting specific demographics, such as children and the elderly. Manufacturers are developing products that are tailored to the unique needs of these age groups, including dosage forms that are easier to administer and formulations that are gentler on sensitive systems.

Local special circumstances:
Qatar has a high expatriate population, with a significant portion of the workforce coming from different countries. This diverse population has different healthcare needs and preferences, leading to a wide range of OTC pharmaceutical products being available in the market. Manufacturers and retailers are catering to these diverse preferences by offering a variety of products from different regions.Additionally, Qatar has a strong healthcare infrastructure, with well-established pharmacies and healthcare facilities. This provides easy access to OTC pharmaceuticals for consumers, further driving the market growth.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in Qatar is also influenced by macroeconomic factors. The country has a high per capita income and a strong economy, which enables consumers to spend more on healthcare products, including OTC pharmaceuticals. Additionally, the government of Qatar has been investing heavily in healthcare infrastructure and promoting healthcare awareness, which has contributed to the growth of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Qatar is experiencing significant growth due to customer preferences for convenience, accessibility, and affordability. The market is also influenced by trends such as the demand for natural and herbal remedies, as well as products targeting specific demographics. Local special circumstances, such as the diverse expatriate population and strong healthcare infrastructure, further contribute to the market growth. The underlying macroeconomic factors, including high per capita income and government investments in healthcare, also play a role in driving the market. Overall, the OTC Pharmaceuticals market in Qatar is expected to continue growing in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)